【24h】

Emerging ultrafast nucleic acid amplification technologies for next-generation molecular diagnostics

机译:新出现的超快核酸放大技术,用于下一代分子诊断

获取原文
获取原文并翻译 | 示例
           

摘要

Over the last decade, nucleic acid amplification tests (NAATs) including polymerase chain reaction (PCR) were an indispensable methodology for diagnosing cancers, viral and bacterial infections owing to their high sensitivity and specificity. Because the NAATs can recognize and discriminate even a few copies of nucleic acid (NA) and species-specific NA sequences, NAATs have become the gold standard in a wide range of applications. However, limitations of NAAT approaches have recently become more apparent by reason of their lengthy run time, large reaction volume, and complex protocol. To meet the current demands of clinicians and biomedical researchers, new NAATs have developed to achieve ultrafast sample-to-answer protocols for the point-of-care testing (POCT). In this review, ultrafast NA-POCT platforms are discussed, outlining their NA amplification principles as well as delineating recent advances in ultrafast NAAT applications. The main focus is to provide an overview of NA-POCT platforms in regard to sample preparation of NA, NA amplification, NA detection process, interpretation of the analysis, and evaluation of the platform design. Increasing importance will be given to innovative, ultrafast amplification methods and tools which incorporate artificial intelligence (AI)-associated data analysis processes and mobile-healthcare networks. The future prospects of NA POCT platforms are promising as they allow absolute quantitation of NA in individuals which is essential to precision medicine.
机译:在过去的十年中,包括聚合酶链反应(PCR)的核酸扩增试验(NAAT)是由于其具有高敏感性和特异性而诊断癌症,病毒和细菌感染的不可或缺的方法。因为NAATS可以识别和辨别甚至几份核酸(NA)和物种的NA序列,所以NAATS已成为各种应用中的金标准。然而,由于其冗长的运行时间,大反应量和复杂的方案,NaAt方法的限制最近变得更加明显。为满足当前对临床医生和生物医学研究人员的需求,新的NAATS已经开发出来实现超快样品 - 应答协议(POCT)。在本次审查中,讨论超大NA-POCT平台,概述了其NA扩增原理以及划定超快NAAT应用的最新进展。主要重点是提供Na-POCT平台关于Na,Na扩增,NA检测过程,分析解释和平台设计的评估的概述。将越来越重要地赋予包括人工智能(AI) - 分配的数据分析过程和移动医疗保健网络的创新,超快放大方法和工具。 NA POCT平台的未来前景很有希望,因为它们允许对精密药物至关重要的个体中NA的绝对定量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号